Cargando…
Role of metabolites of cyclophosphamide in cardiotoxicity
BACKGROUND: The dose-limiting toxic effect of cyclophosphamide (CY) is cardiotoxicity. The pathogenesis of myocardial damage is poorly understood, and there is no established means of prevention. In previous studies, we suggested that for CY-induced cardiotoxicity, whereas acrolein is the key toxic...
Autores principales: | Kurauchi, Koichiro, Nishikawa, Takuro, Miyahara, Emiko, Okamoto, Yasuhiro, Kawano, Yoshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557551/ https://www.ncbi.nlm.nih.gov/pubmed/28807058 http://dx.doi.org/10.1186/s13104-017-2726-2 |
Ejemplares similares
-
Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention
por: Nishikawa, Takuro, et al.
Publicado: (2015) -
Benzene Metabolite 1,2,4-Benzenetriol Induces Halogenated DNA and Tyrosines Representing Halogenative Stress in the HL-60 Human Myeloid Cell Line
por: Nishikawa, Takuro, et al.
Publicado: (2011) -
The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020) -
Association between Dysfunction of the Nucleolar Stress Response and Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Nakagawa, Shunsuke, et al.
Publicado: (2022) -
Cardioprotective effect of curcumin and piperine combination against cyclophosphamide-induced cardiotoxicity
por: Chakraborty, Manodeep, et al.
Publicado: (2017)